Jalra-DP Tablet is a combination medication used for the comprehensive management of type 2 diabetes. It contains Vildagliptin, which increases insulin production from the pancreas, and Dapagliflozin, which helps the kidneys excrete excess sugar through urine. This dual mechanism targets blood sugar control from two different biological pathways.
This treatment helps stabilize blood sugar levels throughout the day and reduces the risk of long-term damage to the nerves and blood vessels. The medication is particularly useful for patients who need more than one active agent to reach their glycemic targets. Consult your doctor for regular monitoring of your kidney function and blood sugar levels while on this therapy.






































































